Cryptogenic organizing pneumonia pathophysiology
|
Cryptogenic Organizing Pneumonia Microchapters |
|
Differentiating Cryptogenic organizing pneumonia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia pathophysiology On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia pathophysiology |
|
Cryptogenic organizing pneumonia pathophysiology in the news |
|
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Serge Korjian M.D.
Overview
Pathophysiology
Pathogenesis
- It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name's, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
1) Injury phase - The early phase of cryptogenic organizing pneumonia.
- It is characterized by the deposition of plasma proteins in the alveolar lumen.
- Mechanism of early phase is an imbalance between coagulation and fibrinolytic cascade and activation of coagulation process which leads to fibrin deposition.[1]
2) Proliferating phase - The second stage of the cryptogenic organizing pneumonia in which there is a formation of fibroinflammatory buds.
- Macrophages and inflammatory cells help in fragmentation of fibrin.
- Activated fibroblasts differentiate into myofibroblasts which are migrating through gaps of the basal lamina.
- Inflammatory cells and fibrin are progressively replaced by aggregated fibroblasts/myofibroblasts intermixed with a loose connective matrix tissue rich in collagen (especially collagen I), fibronectin, procollagen type III and proteoglycans.
- Alveolar epithelial cells proliferate, restoring the continuity of the alveolar-capillary membrane and the integrity of the alveolar unit.
3) Mature phase - The third stage is characterized by the formation of “mature” fibrotic buds.
- In alveolar buds, there are myofibroblasts, organized in concentric rings alternating with layers of collagen bundles.
4)Resolution phase - The fourth stage, this stage usually resolves if there is the preservation of alveolar basal laminae.
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Associated Conditions
Gross Pathology
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis:[2]
- It is characterized by chronic mild interstitial inflammation without fibrosis.
- There is the formation of buds of granulation tissue which is made of fibrous tissue (Masson bodies), mononuclear cells and foamy macrophages, in the distal airspaces which cause secondary bronchiolar occlusion due to the presence of the inflammatory process.
References
- ↑ 1.0 1.1 Cordier JF (2006). "Cryptogenic organising pneumonia". Eur Respir J. 28 (2): 422–46. doi:10.1183/09031936.06.00013505. PMID 16880372.
- ↑ "Cryptogenic organising pneumonia | Radiology Reference Article | Radiopaedia.org".